Though classically associated with hypersensitivity to platinum-based chemotherapies, defects in these genes in HNSCC have been shown to create cell lineages that rely on PARP mechanisms for DNA repair [16,17,18,19,20]. This evidence concerns the gene PARP1 and head and neck squamous cell carcinoma.